0000897069-21-000219.txt : 20210510
0000897069-21-000219.hdr.sgml : 20210510
20210510103322
ACCESSION NUMBER: 0000897069-21-000219
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210510
DATE AS OF CHANGE: 20210510
EFFECTIVENESS DATE: 20210510
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Paragon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001861055
IRS NUMBER: 862707757
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-398700
FILM NUMBER: 21905613
BUSINESS ADDRESS:
STREET 1: C/O FAIRMOUNT FUNDS MANAGEMENT, LLC
STREET 2: 2001 MARKET STREET, SUITE 2500
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: (267) 760-4066
MAIL ADDRESS:
STREET 1: C/O FAIRMOUNT FUNDS MANAGEMENT, LLC
STREET 2: 2001 MARKET STREET, SUITE 2500
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
D
1
primary_doc.xml
X0708
D
LIVE
0001861055
Paragon Therapeutics, Inc.
C/O FAIRMOUNT FUNDS MANAGEMENT, LLC
2001 MARKET STREET, SUITE 2500
PHILADELPHIA
PA
PENNSYLVANIA
19103
(267) 760-4066
DELAWARE
None
None
Corporation
true
2021
Evan
Thompson
c/o Fairmount Funds Management, LLC
2001 Market Street, Suite 2500
Philadelphia
PA
PENNSYLVANIA
19103
Executive Officer
Promoter
Peter
Harwin
Fairmount Funds Management, LLC
2001 Market Street, Suite 2500
Philadelphia
PA
PENNSYLVANIA
19103
Director
Promoter
Biotechnology
Decline to Disclose
- 06b
false
2021-04-26
false
true
true
false
0
10000000
10000000
0
false
2
0
0
0
false
Paragon Therapeutics, Inc.
Evan Thompson
Evan Thompson
President
2021-05-07